SeaStar Medical Holding Corporation (ICU) Revenue History
Annual and quarterly revenue from 2020 to present
ICU Revenue Over Time (2020–2025)
ICU Revenue Growth History
1 of 1 years with positive growth- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- N/A
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
- FY2025 revenue growth
- +814.1%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $495K | +68.9% |
| Q4 2025 | $420K | +526.9% |
| Q3 2025 | $183K | +169.1% |
| Q2 2025 | $338K | — |
| Q1 2025 | $293K | — |
| Q4 2024 | $67K | — |
| Q3 2024 | $68K | — |
| Q2 2024 | $0 | — |
Multi-year avg. share of annual revenue by fiscal quarter
ICU Revenue Analysis (2020–2025)
Current Revenue & Growth
As of June 22, 2026, SeaStar Medical Holding Corporation (ICU) generated trailing twelve-month (TTM) revenue of $1.4 million, reflecting explosive growth of +68.9% year-over-year. The most recent quarter (Q1 2026) recorded $495,000 in revenue, up 17.9% sequentially.
Historical Growth Trajectory
ICU's historical revenue data shows various trends over time. SeaStar Medical Holding Corporation's highest annual revenue of $1.2 million was recorded in 2025, an all-time high.
Peer Comparison
Compared to Healthcare sector peers — including NKTR (-36.2% YoY), TPVG, and AKBA (+25.7% YoY) — ICU has outperformed the peer group in revenue growth. Compare ICU vs NKTR →
ICU Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ICUCurrent | $1M | +68.9% | - | -986.6% | |
 NKTR | $55M | -36.2% | -18.4% | -236.8% | |
 TPVG | $97M | - | - | 77.9% | |
 AKBA | $236M | +25.7% | -4.3% | 9.9% | |
 CPRX | $589M | +11.7% | +37.7% | 43.8% | |
 XOMA | $52M | -3.3% | +12.2% | 21.8% |
ICU Historical Revenue Data (2020–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.2M | +814.1% | $1.2M | 95.7% | $-12,175,000 | -986.6% |
| 2024 | $135K | - | $135K | 100.0% | $-17,842,000 | -13216.3% |
| 2023 | $0 | - | $0 | - | $-14,210,000 | - |
| 2022 | $0 | - | $0 | - | $-11,609,000 | - |
| 2021 | $0 | - | $0 | - | $-4,449,000 | - |
| 2020 | $0 | - | $0 | - | $-6,453,000 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
6+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ICU — Frequently Asked Questions
Quick answers to the most common questions about buying ICU stock.
Is ICU's revenue growth accelerating or slowing?
ICU revenue growth is accelerating. TTM revenue reached $1M, up +68.9% year-over-year — ahead of the 5-year CAGR of N/A. This indicates the business is expanding faster than its historical baseline.
What is ICU's revenue history from 2020 to 2026?
SeaStar Medical Holding Corporation (ICU) revenue history spans 2020 to 2026. TTM revenue as of 2026 is $1M, growing at +68.9% YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is ICU's long-term revenue growth rate (CAGR)?
SeaStar Medical Holding Corporation's 5-year revenue CAGR of N/A reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +68.9% is above this long-term average. CAGR is the most reliable measure of sustained revenue momentum for ICU.
Why does ICU's quarterly revenue fluctuate?
ICU quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. SeaStar Medical Holding Corporation's revenue data from 2020 to 2026 shows full historical quarterly detail on this page.
How is ICU's revenue distributed by segment?
ICU reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does ICU's revenue compare to industry peers?
SeaStar Medical Holding Corporation (ICU) with TTM revenue of $1M and +68.9% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.